9 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DERMAL CURETTE 2 mm

Device
EU MDR · Eu Md Class 2a ·Kai Industries Co., Ltd.·On the market·29 countries

TOP NEUROPOLE NEEDLE TL 22G 100-2mm

Device
EU MDR · Eu Md Class 2a ·TOP Corporation·On the market·5 countries

TOP NEUROPOLE NEEDLE TL 20G 145-2mm

Device
EU MDR · Eu Md Class 2a ·TOP Corporation·On the market·5 countries

TOP NEUROPOLE NEEDLE SC-K 22G 100-2mm

Device
EU MDR · Eu Md Class 2a ·TOP Corporation·On the market·5 countries

INJECTOR FORCEMAX UP 2MM CH 23G 6MM, model no. NM-401L-0623 - Product Usage: Used with endoscopes to perform endoscopic injection for the treatment of esophageal and gastric varices and for submucosal injection in the digestive tract.

FDA Enforcement
Class II ·Terminated·Aomori Olympus Co., Ltd.·February 17, 2021

INJECTOR FORCEMAX UP 2MM CH 25G 6MM, model no. NM-401L-0625 - Product Usage: Used with endoscopes to perform endoscopic injection for the treatment of esophageal and gastric varices and for submucosal injection in the digestive tract.

FDA Enforcement
Class II ·Terminated·Aomori Olympus Co., Ltd.·February 17, 2021

INJECTOR FORCEMAX UP 2MM CH 23G 3MM, model no. NM-401L-0523 - Product Usage: Used with endoscopes to perform endoscopic injection for the treatment of esophageal and gastric varices and for submucosal injection in the digestive tract.

FDA Enforcement
Class II ·Terminated·Aomori Olympus Co., Ltd.·February 17, 2021

INJECTOR FORCEMAX UP 2MM CH 25G 4MM, model no. NM-401L-0425 - Product Usage: Used with endoscopes to perform endoscopic injection for the treatment of esophageal and gastric varices and for submucosal injection in the digestive tract.

FDA Enforcement
Class II ·Terminated·Aomori Olympus Co., Ltd.·February 17, 2021

INJECTOR FORCEMAX UP 2MM CH 25G 5MM, model no. NM-401L-0525 - Product Usage: Used with endoscopes to perform endoscopic injection for the treatment of esophageal and gastric varices and for submucosal injection in the digestive tract.

FDA Enforcement
Class II ·Terminated·Aomori Olympus Co., Ltd.·February 17, 2021